Corporate News
Provided by:
Set Up E-mail Alerts For Corporate News »
Major corporate news developments tracked by the staff at StreetInsider.com
-
-
-
-
-
-
-
Merck (MRK): FDA Grants Priority Review to Application for KEYTRUDA Plus Chemo as First-Line Treatment of Patients With Malignant Mesothelioma
-
-
-
-
-
-
-
Immunocore (IMCR) converts Phase 2/3 TEBE-AM clinical trial into registrational Phase 3 trial of KIMMTRAK
-
-
-
-
-
-
-
Milestone Pharmaceuticals Inc. (MIST) Announces FDA Acceptance of New Drug Application for CARDAMYST
-
-
-
-
-
-
-
NexGen Energy (NXE) Announces Additional Mineralization Discovered at Patterson Corridor East
-
-
-
-
-
-
-
Terran Orbital Corporation (LLAP) Appoints Peter Krauss as COO, Adarsh Parekh as CFO
-
-
-
-
-
-
-
Fortress Transportation (FTAI) Prices 2.09M Share Secondary Offering at $82/sh
-
-
-
-
-
-
-
Arrowhead Pharmaceuticals (ARWR) Presents New Phase 2 Data of Zodasiran
-
324,142 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving Corporate News reports.